Log in
Enquire now
AbbVie Ventures

AbbVie Ventures

AbbVie Ventures, an Illinois-based company, that invests in emerging biotech and pharmaceutical companies.

OverviewStructured DataIssuesContributors

Contents

abbvie.com...es.html
Is a
Organization
Organization
Company
Company
Venture capital firm
Venture capital firm
Investor
Investor

Company attributes

Industry
Pharmaceutical industry
Pharmaceutical industry
Biology
Biology
Biotechnology
Biotechnology
Technology
Technology
Location
Tokyo
Tokyo
‌
North Chicago, Illinois
Japan
Japan
B2X
B2B
B2B
CEO
Richard A. Gonzalez
Richard A. Gonzalez
Pitchbook URL
pitchbook.com/profiles.../61957-36
Legal Name
AbbVie Inc
Parent Organization
AbbVie Inc.
AbbVie Inc.
Spun Out From
Abbott Biotech Ventures
Abbott Biotech Ventures
Number of Employees (Ranges)
10,001+
Number of Employees
1,243
Investors
Ribon Therapeutics
Ribon Therapeutics
Founded Date
2012
CFO
‌
Robert Michael
Key People
‌
Jeffrey Stewart
0
‌
Robert Michael
0
Richard A. Gonzalez
Richard A. Gonzalez
0
‌
Azita Saleki-Gerhardt
0
‌
Laura J. Schumacher
0
‌
Henry O. Gosebruch
0
‌
Timothy J. Richmond
0
‌
Rae L. Livingston
0
Country
Japan
Japan

Venture Capital Firm attributes

Invested in
Exicure
Exicure
Rodeo Therapeutics
Rodeo Therapeutics
Artios
Artios
‌
Quentis Therapeutics
Rheostat Therapeutics
Rheostat Therapeutics
ApoGen Biotechnologies
ApoGen Biotechnologies
0
Aquinnah Pharmaceuticals
Aquinnah Pharmaceuticals
Palleon Pharmaceuticals
Palleon Pharmaceuticals
...

Other attributes

Company Operating Status
Active

AbbVie Biotech Ventures - also known as AbbVie Ventures - is a venture capital firm based in North Chicago, Illinois. The firm was founded in 2009, and it is a subsidiary of AbbVie. AbbVie itself was a business operation of Abbott Laboratories until 2013 when it became a separate company. As of October 2019, the firm has invested in 47 companies and maintains its ownership on 25 active companies.

AbbVie Ventures focuses on investing in companies developing solutions in the fields of oncology, immunology, and neuroscience. The firm focuses on providing capital for eight companies each year. It prefers to invest in companies at the seed or series A stage.

The company invests in novel transformational therapeutics for pre-clinical stages. Some of the companies that Abbvie Biotech Ventures has invested in include Alector Therapies to Remember, AM-Pharma, Apogen, Aquinnah, artios, Caraway Therapeutics, Carisma Therapeutics, Disarm Therapeutics, eFFECTOR, E-scape Bio, Lodo Therapeutics, Magnolia NeuroSciences, MORPHIC Therapeutic, PACT Pharma, Palleon Pharmaceuticals, Petra Pharma, Prevail Therapeutics, Quentis Therapeutics, ribometrix.

Timeline

No Timeline data yet.

Associated Investment Funds

Accelerator Batches

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Funding Rounds Participated In

Further Resources

Title
Author
Link
Type
Date

2021 100 Best Companies to Work For®

https://youtu.be/sbcf2aI72P0

Web

April 16, 2021

AbbVie Biotech Ventures - Investments, Portfolio & Company Exits

https://www.crunchbase.com/organization/abbvie-biotech-ventures/recent_investments

Web

AbbVie Ventures

https://www.abbvie.com/partnerships/abbvie-ventures.html

Web

Can Partnerships Help Bring an End to NTDs? Journey of Sight World Premiere and Panel Discussion

https://youtu.be/FzhO_tyLT8Q

Web

January 28, 2022

Portfolio

https://www.abbvie.com/partnerships/abbvie-ventures/portfolio.html

Web

References

Find more companies like AbbVie Ventures

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.